Kiora Pharmaceuticals Files 8-K for Material Agreement
Ticker: KPHMW · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1372514
| Field | Detail |
|---|---|
| Company | Kiora Pharmaceuticals Inc (KPHMW) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-news
Related Tickers: KPRX
TL;DR
Kiora Pharma (KPRX) filed an 8-K for a new material agreement. Details to follow.
AI Summary
Kiora Pharmaceuticals, Inc. filed an 8-K on June 3, 2025, reporting a material definitive agreement entered into on May 30, 2025. The filing also includes Regulation FD disclosures and financial statements/exhibits. The company was formerly known as Eyegate Pharmaceuticals Inc.
Why It Matters
This filing indicates a significant business development for Kiora Pharmaceuticals, potentially impacting its operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Players & Entities
- KIORA PHARMACEUTICALS, INC. (company) — Registrant
- EYEGATE PHARMACEUTICALS INC (company) — Former company name
- May 30, 2025 (date) — Date of earliest event reported
- June 3, 2025 (date) — Date of report
FAQ
What is the nature of the material definitive agreement entered into by Kiora Pharmaceuticals?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on May 30, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 30, 2025.
What was Kiora Pharmaceuticals' former company name?
Kiora Pharmaceuticals, Inc. was formerly known as Eyegate Pharmaceuticals Inc.
What is the business address of Kiora Pharmaceuticals?
The business address is 332 Encinitas Boulevard, Suite 102, Encinitas, CA 92024.
What is the SEC file number for Kiora Pharmaceuticals?
The SEC file number for Kiora Pharmaceuticals is 001-36672.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding KIORA PHARMACEUTICALS INC (KPHMW).